Fingerprint
Dive into the research topics where Hilma van der Horst is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL
van der Horst, H. J., Csikós, T., Quik, M., van der Schans, J. J., de Lint, K., Nuñez Moreno, G., Guan, M., Karagoz, K., Breij, E. C. W., Santegoets, K. C. M., Chamuleau, M. E. D., Roukens, M. G., Overdijk, M. B. & Mutis, T., 1 Dec 2025, In: Blood cancer journal. 15, 1, 156.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Enhancing Fc-mediated effector functions of monoclonal antibodies: The example of HexaBodies
van der Horst, H. J. & Mutis, T., Nov 2024, In: Immunological reviews. 328, 1, p. 456-465 10 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile106 Downloads (Pure) -
Moving cancer therapy forward: Engineered antibodies for the treatment of B-cell malignancies
van der Horst, H. J., 2 Nov 2021, Amsterdam: s.n.. 204 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
Open Access -
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
Oostindie, S. C., van der Horst, H. J., Lindorfer, M. A., Cook, E. M., Tupitza, J. C., Zent, C. S., Burack, R., VanDerMeid, K. R., Strumane, K., Chamuleau, M. E. D., Mutis, T., de Jong, R. N., Schuurman, J., Breij, E. C. W., Beurskens, F. J., Parren, P. W. H. I. & Taylor, R. P., 31 Aug 2019, In: Haematologica. 104, 9, p. 1841-1852 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Downloads (Pure) -
Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies
Van der Horst, H. J., de Jonge, A. V., Hiemstra, I. H., Gelderloos, A. T., Berry, D. R., Hijmering, N. J., de Jong, D., Chamuleau, M. E. D., Zweegman, S., Breij, E. C. W., Roemer, M. G. M. & Mutis, T., 13 Nov 2019, In: Blood. 134Research output: Contribution to journal › Meeting Abstract › Academic